Posts by: Steve Bryson PhD

Steve Bryson PhD

Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.

January 15, 2021January 15, 2021

Plant Extract Shows Promise as Parkinson’s Therapy in Rodent Study

News

An extract from three plant species reduced signs of motor disturbances in rodent models of Parkinson’s disease and lessened the associated molecular defects of the cellular recycling process known ... Read more

January 14, 2021January 14, 2021

Focused Ultrasound May Help Treat Motor Symptoms, Trial Finds

News

People with Parkinson’s disease with symptoms affecting one side of the body, who were treated with focused ultrasound targeting the affected brain region, showed an improvement in motor features ... Read more

January 14, 2021January 14, 2021

MIND Diet Delays Parkinson’s Onset, Research Shows

News

Later age at Parkinson’s disease onset is associated with high adherence to the MIND diet and benefits women more than three times as much as it does men, a study ... Read more

January 12, 2021January 12, 2021

Smartphone App Shows COVID-19 Lockdowns Led to Big Drop in Walking

News

A smartphone application designed to measure and monitor the walking mobility of people with Parkinson’s disease captured a 44% decrease in daily activities during the COVID-19 pandemic lockdowns, a study ... Read more

January 12, 2021January 13, 2021

Antioxidant Nanozyme Found to Block Parkinson’s Development in Mice

News

Treatment with the antioxidant metal-alloy nanozyme reduced the build-up (aggregation) and transmission of disease-causing alpha-synuclein protein in the nerve cells and brains of a Parkinson’s disease mouse model, a ... Read more

December 17, 2020December 17, 2020

Electrical Stimulation May Correct How Brainwaves Are Affected by Parkinson’s, Study Says

News

Changes in how brainwaves synchronize, known to occur in people with Parkinson’s disease, originate from distinct nerve cell networks in multiple brain regions involved in motor control, a study ... Read more

December 14, 2020December 14, 2020

Visual Hallucinations Linked to Retinal Thinning in Parkinson’s, Study Reports

News

Visual hallucinations in people with Parkinson’s disease are associated with a thinning of the inner layers of the eye’s retina, an exploratory study reported. Published in the journal Nature ... Read more

December 11, 2020December 11, 2020

TOM20 Protein Rescues Nerve Cells Damaged in Parkinson’s in Rat Study

News

Production of the protein TOM20 rescued nerve cells that are damaged in people with Parkinson’s disease due to the toxic buildup of alpha-synuclein protein, a study in rats revealed. ... Read more

December 10, 2020December 10, 2020

Scientists Engineer Tomato That Could Be Low-cost Source of Levodopa

News

Scientists have created a tomato enriched in levodopa, or L-DOPA, a standard therapy for people with Parkinson’s disease. These tomatoes could represent a scalable, low-cost alternative L-DOPA source for ... Read more

December 9, 2020December 9, 2020

EEG Plus Machine-learning Identifies Mild Cognitive Impairment, Study Finds

News

Using non-invasive, dry-electroencephalography (EEG) and machine-learning computer algorithms, researchers were able to distinguish between Parkinson’s disease patients with and without mild cognitive impairments with 80% accuracy, early results of ... Read more